Hovione Unveils New Continuous Tableting Line at Lisbon R&D Centre
Hovione is proud to announce the opening of a state-of-the-art continuous tableting (CT) line at its R&D Center in Lisbon.
Oops! Your browser version is not supported by our website.
Please use these following browsers to view this page:
Hovione is proud to announce the opening of a state-of-the-art continuous tableting (CT) line at its R&D Center in Lisbon.
Hovione and GEA today announced a strategic collaboration to advance Continuous Tableting.
The agreement furthers Hovione´s ability to bring the benefits of continuous tableting, including reduced time to market and increased supply chain flexibility, to pharmaceutical customers globally
Pharmaceutical Technology, 10 October 2022
The new ConsiGma® CDC Flex delivers unprecedented flexibility, simplicity, and cost-efficiency in continuous direct compression.
Welcome to the future of drug product development
Manufacturing Chemist, 7 September 2022
Hovione won the 2023 CDMO Leadership Award across all six categories across all three groups of respondents